Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3140

Patent

active

048778060

ABSTRACT:
The method which comprises administering to a tumor-containing animal derivatives of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives, preferably a compound having the following structural formula: ##STR1## or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4670461 (1987-06-01), Haugwitz et al.
"The Structure of the Benzene-Maleimide Photosynthetic Product (Mitindomide)", George R. Pettit, Kenneth D. Paull, Cherry L. Herald, Delbert L. Herald and Joseph R. Riden, Cancer Research Institute and Department of Chemistry, Arizona State University, pp. 2291-2294.
"Screening at the National Cancer Institute", Abraham Goldin, John M. Venditti and Stephen K. Carter, National Cancer Institute Monograph: USA-USSR.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-626329

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.